Top news of the week: 13.10.2020.
#analyticavirtual #KiranMazumdarShaw #Covid19 #biotechnology #IPO #biospace #lifesciences #pharmaceuticals #pharma #labtech
Companies And Industries
RT @ETNOWlive: #KiranMazumdarShaw entered into this rarefied billionaire group in 2004, when @Bioconlimited, the #pharma company she founded 42 years ago, was listed on Indian stock exchanges. @kiranshaw
https://t.co/GKgKFTXEB7
OpenThrowback: When biotech jackpot propelled Kiran Mazumdar-Shaw to India’s rarefied billionaire group
Shaw, 67, entered into this rarefied billionaire group in 2004, when Biocon, the pharma company she founded 42 years ago, was listed on Indian stock exchanges.
RT @adamfeuerstein: ‘They gave me Regeneron’: How Trump’s case of #Covid19 affects biotech, medicine, and the FDA. w/ guest, George Scangos of $VIR https://t.co/uTgPnMNHD2 This was fun episode to produce, done on the fly after last night's Trump video. We hope you like it.
OpenListen: ‘They gave me Regeneron’: How Trump’s case of Covid-19 affects biotech, medicine, and the FDA
We unpack Trump's endorsement of Regeneron and his apparent acceptance that there won't be a Covid-19 vaccine before Election Day.
4 Biotech IPOs this Week: Kronos, Shattuck, Spruce and Aziyo
#biospace #lifesciences #biotechnology #pharmaceuticals #IPO
https://t.co/14fvDnsTX5
Open4 Biotech IPOs this Week: Kronos, Shattuck, Spruce and Aziyo
It’s been a fairly busy week for biotech initial public offerings (IPOs) with four announcing their list pricing. Here’s a look.
Biopharma IPOs on a roll, with more to come before year-end
The appetite for biopharma IPOs this year has been voracious with no signs of a slowdown anytime soon. Year-to-date, a total of $14.63 billion was raised from 66 new global issues, a total ...
RT @analyticaFair: Get access to the entire range of #QualityControl 🔬✅💯 solutions at #analyticavirtual (Oct 19-23) as world's biggest event of #analysis #labtech and #biotech industry in 2020
https://t.co/4uWIR1kQgF
@buchilabeqpt @elementargroup @GERSTEL_ @newsfrom_MP @WatersCorp
#analytica2020 https://t.co/7rMqsxVYqN
OpenQuality control in theory and practice
analytica presents the entire range of quality control in theory and practice. Don't miss this unique group of exhibitors and attractive supporting program!
Chutes & Ladders—Sanofi CSO Nabel steps down in favor of insider Nestle https://t.co/o9Yk9FgLce https://t.co/lNRgadHCtv
OpenChutes & Ladders—Sanofi CSO Nabel steps down in favor of insider Nestle
Sanofi's CSO Nabel steps down from role; BioMarin adds Eggan to head early research; Shams joins ProQR as CSO.
With clinical focus elsewhere, Germany's Merck sells off osteoarthritis drug to Novartis https://t.co/WPWuEJ690k https://t.co/eMDiohPQ7Y
OpenWith clinical focus elsewhere, Germany's Merck sells off osteoarthritis drug to Novartis
Germany’s Merck is pretty busy with its focus on cancer (notably its Pfizer-partnered Bavencio) and neurology, so it's decided to make a quick buck turfing out an unwanted bone drug to ...
#GoodDayBIO: New #IamBIO episode with Deerfield discussing biotech's future. @Regeneron CEO says the real evidence about how good a drug is has to come from larger clinical trials. @POETbiofuels explains how biofuels can help farmers and the environment. https://t.co/dWHGaCA9OY
OpenThe golden age of medicine
BIO Investor Forum Digital kicks off tomorrow—and to get ready, Dr. Michelle talks to a biotech investor about everything from COVID-19 therapeutics and diagnostics to the impact of drug ...